Dynavax Technologies Long Term Debt 2010-2022 | DVAX
Dynavax Technologies long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
Dynavax Technologies Annual Long Term Debt
(Millions of US $) |
| 2021 |
$220 |
| 2020 |
$180 |
| 2019 |
$179 |
| 2018 |
$101 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
| 2014 |
$10 |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Dynavax Technologies Quarterly Long Term Debt
(Millions of US $) |
| 2022-03-31 |
$221 |
| 2021-12-31 |
$220 |
| 2021-09-30 |
$220 |
| 2021-06-30 |
$220 |
| 2021-03-31 |
$180 |
| 2020-12-31 |
$180 |
| 2020-09-30 |
$180 |
| 2020-06-30 |
$180 |
| 2020-03-31 |
$180 |
| 2019-12-31 |
$179 |
| 2019-09-30 |
$178 |
| 2019-06-30 |
$177 |
| 2019-03-31 |
$176 |
| 2018-12-31 |
$101 |
| 2018-09-30 |
$100 |
| 2018-06-30 |
$100 |
| 2018-03-31 |
$99 |
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-09-30 |
|
| 2015-06-30 |
$8 |
| 2015-03-31 |
$9 |
| 2014-12-31 |
$10 |
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
$15 |
| 2009-06-30 |
$15 |
| 2009-03-31 |
$15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.637B |
$0.439B |
|
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
|
